FDA panel backs first-of-its-kind flu vaccine using mRNA technology
The Food and Drug Administration is evaluating Moderna's new shot, dubbed mFlusiva, for older Americans ahead of the winter flu season.
Original Source
Read the full article at Pbs →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.